Chemoinformaics analysis of 2-AMINO-5,6,7,8-TETRAHYDROXY-6-(1,2,3-TRIHYDROXYPROPYL)-3,4A,7,8A-TETRAHYDROPTERIDIN-4-ONE
Molecular Weight | 323.262 | nRot | 3 |
Heavy Atom Molecular Weight | 306.126 | nRig | 8 |
Exact Molecular Weight | 323.108 | nRing | 2 |
Solubility: LogS | -1.363 | nHRing | 2 |
Solubility: LogP | 1.923 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 5 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 12 | APOL | 38.2815 |
nHD | 9 | BPOL | 20.2025 |
QED | 0.651 |
Synth | 1.783 |
Natural Product Likeliness | 0.841 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.017 |
HIA | 0.009 |
CACO-2 | -4.961 |
MDCK | 0.0000132 |
BBB | 0.29 |
PPB | 0.853614 |
VDSS | 0.293 |
FU | 0.137251 |
CYP1A2-inh | 0.061 |
CYP1A2-sub | 0.067 |
CYP2c19-inh | 0.046 |
CYP2c19-sub | 0.052 |
CYP2c9-inh | 0.232 |
CYP2c9-sub | 0.566 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.169 |
CYP3a4-inh | 0.031 |
CYP3a4-sub | 0.08 |
CL | 6.299 |
T12 | 0.919 |
hERG | 0.025 |
Ames | 0.045 |
ROA | 0.796 |
SkinSen | 0.941 |
Carcinogencity | 0.151 |
EI | 0.988 |
Respiratory | 0.512 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.832138 |